Hi Mr. lybrate-user,
I appreciate you seeking help. Well, BCR-ABL ratio monitoring is usually done regularly to understand not only the disease status but also to understand as to how effective the treatment has been in controlling the disease. As I understand, a reducing trend is favorable. However, your hematology-oncologist can best explain the status/ outlook as is contextually applicable in your case. Hope this helps. Do take care and all the very best.
Suggestions offered by doctors on Lybrate are of advisory nature i.e., for educational and informational purposes only. Content posted on, created for, or compiled by Lybrate is not intended or designed to replace your doctor's independent judgment about any symptom, condition, or the appropriateness or risks of a procedure or treatment for a given person.